Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Among them, retatrutide has shown significant clinical advantages in phase II clinical trials, reducing the weight of obese patients by up to 24.2% in 48 weeks and lowering the HbA1c of type 2 diabetes patients by 2.2% in 36 weeks (49, 50)
A study by Stoffel et al
K.Pasqual-MeloG.BodnarY.GandhirajanR
Scientific References 5 sources 1 Drucker DJ Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1 Cell Metabolism 27(4) 2018PMID: 29617641 PubMed 2 Wilding JPH, Batterham RL, Calanna S, et al
Gke R, Larsen PJ, Mikkelsen JD, Sheikh SP
Recalculate your units using the formula
US$ 23.94
US$ 24.54
US$ 20.54
US$ 28.22
US$ 20.53
US$ 22.52
